Back to search

Article

Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: a Mendelian Randomisation study

2022-04-28

Abstract excerpt

Fibroblast growth factor 23 (FGF-23) is associated with a range of cardiovascular and non-cardiovascular diseases in conventional epidemiological studies, but substantial residual confounding may exist. Mendelian randomisation approaches can help control for such confounding. SCALLOP consortium data on 19,195 participants were used to generate an FGF-23 genetic score. Data from 337,448 UK Biobank participants were...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3d446ef6-84a4-5a8f-a481-c06905617656
DOI
10.1101/2022.04.27.22273667
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: a Mendelian Randomisation studyDOI 10.1101/2022.04.27.22273667
Select a neighboring publication to make it the new centre.